pharma · Hemorrhoids · Persistent or Recurrent Cutaneous T-Cell Lymphoma · CTOR
CITIUS ONCOLOGY
CITIUS ONCOLOGY, INC.
News and analysis for CITIUS ONCOLOGY on NovaPharmaNews — regulatory, clinical, and market coverage.
Cranford, USA HQ
2024 Founded
5 Employees
Public company Type
CTOR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cranford, USA
- Founded
- 2024
- Employees
- 5
- Programs
- 3
- Drugs
- 8
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning CITIUS ONCOLOGY — regulatory, clinical, and market coverage.
News and analysis for CITIUS ONCOLOGY on NovaPharmaNews — regulatory, clinical, and market coverage.